Specifically, it was revealed that MeCP2 binds with GPC5-AS1 on the methylated CpG sites in the promoter regions, and MeCP2 silencing induced a significant increase in GPC5-AS1 expression in GC cells. The gene discussed is GPC5; the disease is gastric cancer.